Come up with a name for your new list and we'll add to it:
Personalized Biomarkers raised a round of funding on August 10, 2017. Investors include
Victory Square Technologies.
Personalized Biomarkers develops test kits that reliably predict the expected response to a number of therapies prior to prescription, with an initial focus on diabetes. Within this field, five potent…